ARSANIS
Arsanis is a clinical-stage biopharmaceutical company focused on applying monoclonal antibody (mAb) immunotherapies to address serious infectious diseases. A deep understanding of the pathogenesis of infection, paired with access to some of the most advanced mAb discovery techniques and platforms available today, has positioned Arsanis to build and advance a pipeline of novel mAbs with multiple mechanisms of action and high potency against their intended targets. The companyโs lead clinical p... rogram, ASN100, is aimed at serious Staphylococcus aureus infections and is being evaluated in Phase 2 clinical trial for the prevention of S. aureus pneumonia in high-risk, mechanically ventilated patients. In addition to ASN100, its preclinical pipeline is comprised of mAbs targeting multiple serious bacterial and viral pathogens, including respiratory syncytial virus. Arsanis is a U.S. company headquartered in Waltham, Massachusetts, with European research and preclinical development operations headquartered in Vienna, Austria (Arsanis Biosciences GmbH).
ARSANIS
Industry:
Biotechnology Health Care Life Science
Founded:
2010-01-01
Address:
Vienna, Wien, Austria
Country:
Austria
Website Url:
http://www.arsanis.com
Total Employee:
11+
Status:
Closed
Contact:
431-799-0117
Email Addresses:
[email protected]
Total Funding:
120.27 M USD
Technology used in webpage:
Domain Not Resolving IPv6 GStatic Google Static Content Akamai Hosted
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
SV Health Investors
SV Health Investors investment in Series D - Arsanis
OrbiMed
OrbiMed investment in Series D - Arsanis
EMBL Ventures
EMBL Ventures investment in Series D - Arsanis
GV
GV investment in Series D - Arsanis
Polaris Partners
Polaris Partners investment in Series D - Arsanis
Alexandria Venture Investments
Alexandria Venture Investments investment in Series D - Arsanis
Bill & Melinda Gates Foundation
Bill & Melinda Gates Foundation investment in Series D - Arsanis
Bill & Melinda Gates Foundation
Bill & Melinda Gates Foundation investment in Grant - Arsanis
SV Health Investors
SV Health Investors investment in Series C - Arsanis
SV Health Investors
SV Health Investors investment in Debt Financing - Arsanis
Official Site Inspections
http://www.arsanis.com
- Host name: 104.21.66.39
- IP address: 104.21.66.39
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago